Turtle Cameron, CBO at Eidos Therapeutics, holds 12.57K shares in BridgeBio Pharma (Ticker: BBIO), holds 50.62K shares in Eidos Therapeutics (Ticker: EIDX).

See the Hottest Stocks Based on Insider Trading >

Turtle Cameron
Eidos Therapeutics (EIDX)
CBO

Ranked #73,725 out of 78,624 Corporate Insiders

Profitable Transactions

1 out of 6 Profitable Transactions

Average Return

-40.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

88.06%

EIDX

11.94%

BBIO

A breakdown of Turtle Cameron's holdings

See the Top Stocks by Insiders

Insider Roles

Eidos Therapeutics
(EIDX)

CBO

BridgeBio Pharma
(BBIO)

SVP, Portfolio Management and Corporate Developmen

Roles that Turtle Cameron holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Eidos Therapeutics
(EIDX)

Rating:Informative Sell

Date:Sep 06, 2019 - Sep 06, 2020

Return:+2.10%

The most profitable trade made by Turtle Cameron

See the Latest Stocks Traded by Insiders

Turtle Cameron's Trading History

EIDX

Eidos Therapeutics

Nov 13, 2020

CBO

Uninformative Sell

―

$4.56M

BBIO

BridgeBio Pharma

Nov 25, 2020

SVP, Portfolio Management and Corporate Developmen

Uninformative Sell

235.16K

$617.47K

List of latest transactions for each holding click on a transaction to see Turtle Cameron's performance on stock

See All Insider Trading from Today

Turtle Cameron insider profile FAQ

What is the percentage of profitable transactions made by Turtle Cameron?

The percentage of profitable transactions made by Turtle Cameron is 17%.

What is the average return per transaction made by Turtle Cameron?

The average return per transaction made by Turtle Cameron is -40.30%.

What stocks does Turtle Cameron hold?

Turtle Cameron holds: EIDX, BBIO stocks.

What was Turtle Cameron’s latest transaction?

Turtle Cameron latest transaction was an Uninformative Sell of $235.16K.

What was Turtle Cameron's most profitable transaction?

Turtle Cameron’s most profitable transaction was an Informative Sell of EIDX stock on September 6, 2019. The return on the trade was 2.10%.

What is Turtle Cameron's role in Eidos Therapeutics?

Turtle Cameron's role in Eidos Therapeutics is CBO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Turtle Cameron Insider Profile

Turtle Cameron Eidos Therapeutics (EIDX)CBO